Katy McCortney
@KatyMccortney
Laboratory manager for the Nervous System Tumor Bank (#NSTB) at Northwestern University, Feinberg School of Medicine, department of Neurological Surgery.
ID:1112754964198289409
https://www.feinberg.northwestern.edu/sites/nstb/ 01-04-2019 16:33:52
282 Tweet
315 Takipçi
224 Takip Edilen
MBTI's goal of training the next generation is possible in part because of support like the NREF Research Fellowship Grant, recently awarded to Mark Youngblood. Learn about the #meningioma project this grant enabled during Dr. Youngblood's Neurosurgery at NM #residency below. (1/2)
How to send off a neuropathologist as he embarks on the step of his career as an attending physician:
Step 1. Get a cake. 🎂
Step 2. Use a brain knife to cut the cake 🧠 🔪
Step 3. Marvel at his cutting skills 😁
Matthew McCord, MD We’ll miss you!
#pathtwitter #neuropath #pathology
Our biobank turned 10 years old this spring! In that time, we’ve sent tissue samples all over the world!
To help us celebrate our 10th anniversary, please consider donating $10 via our donation page: feinberg.northwestern.edu/sites/nstb/pat…
Malnati Brain Tumor Institute at Northwestern Neurosurgery at NM Lurie Cancer Center #BTAM
For #LabWeek2024 we are holding Lab Olympics 🥼🏅
Today’s events: pipette tip shooting & single hand speed cryotube uncapping and recapping.
#laboratory #research #NSTB Malnati Brain Tumor Institute at Northwestern
ASCI NM Ophthalmology Craig Horbinski, MD, PhD, was elected to @The_ASCI
for his lab's work in improving the care of patients with gliomas — tumors in the brain or nervous system that form from glial cells.
Our biomarker predicting #meningioma outcomes and radiotherapy responses is out now in Nature Medicine! rdcu.be/dqGku. Tour de force from William C Chen, Stephen Magill MD, PhD, Sahm Lab, Akash Patel, Wenya Linda Bi, NRG Oncology, and many others! UCSF Neurosurgery UCSF Helen Diller Family Comprehensive Cancer Ctr
Very excited for our new study showing that driver mutation variant allelic frequency is a useful tumor purity marker and can identify glioma samples at risk of false negative results in MGMT promoter methylation testing. Craig Horbinski Pouya Jamshidi, MD
link.springer.com/article/10.118…